| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.003 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.00017 | 1 |